6-Amino-5-bromoquinoxaline是一个片段分子，CAS号为50358-63-9，可作为分子拼接、扩展和修饰的重要骨架，为新型候选药物的设计与筛选提供结构基础与研究工具，常用于药物发现、药物合成等相关研究。

Estradiol valerianate 是一种合成的雌性激素，能够与其它甾类激素联用。

JNJ-26146900 is a nonsteroidal androgen receptor (AR) ligand with tissue-selective activity in rats. JNJ-26146900 binds to the rat AR with a K(i) of 400nM.

LX1作为一种化合物，专门针对雄激素受体(AR)、AR变异体及类固醇合成酶AKR1C3，用于抗前列腺癌治疗。该化合物通过抑制AKR1C3酶活性，阻止雄烯二酮向睾酮的转化，并降低AR及AR-V7的表达，从而下调其靶基因。此外，LX1能够克服肿瘤细胞对Enzalutamide的耐药性，并且与之联合应用时能够进一步抑制肿瘤生长。

Epiandrosterone (EpiA) 是一种人内源性代谢物和类固醇激素, 具有弱雄激素特性。

Lubabegron, also known as LY591281; LY488756 fumarate, is a veterinary drug used to reduce ammonia emissions from animals and their waste. Ammonia emissions are a concern in agricultural production because of detrimental effects on the environment, human health, and animal health. Lubabegron was approved by the U.S. Food and Drug Administration in 2018 for use in feedlot cattle. Lubabegron is a beta-adrenergic receptor agonist that has the effect of increasing the breakdown of fats and increasing energy expenditure in cells.

steroidal androgen receptor agonist

ARD-1676为口服有效的雄激素受体(AR) PROTAC降解剂，结合了AR配体与cereblon配体。该化合物能降解体内外的AR，并在小鼠异种移植VCaP肿瘤模型中显示抑制肿瘤生长的活性。

JJH260 is an N-hydroxy hydantoin carbamate that inhibits androgen-induced gene 1 (AIG1), an enzyme that hydrolyzes fatty acid esters of hydroxy fatty acids (FAHFAs). It blocks the hydrolysis of 9-PAHSA with an IC50 value of 0.57 μM. JJH260 also inhibits the novel FAHFA hydrolase androgen-dependent TFPI-regulating protein (ADTRP; IC50 = 8.5 μM), as well as the serine hydrolase ABHD6 and the lysophospholipases LYPLA1 and LYPLA2. JJH260 inhibits the FAHFA hydrolase activity of LNCaP and T cell lysates and intact cells.